Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04340063 · ClinicalTrials.gov registry record · NA
Amplify Gait to Improve Locomotor Engagement in Spinal Cord Injury
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT04340063: Completed NA study, sponsored by VA Office of Research and Development.
NCT04340063 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04340063, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Spinal cord injury (SCI) affects \~42,000 Veterans. The VA provides the single largest network of SCI care in the nation. The lifetime financial burden of SCI can exceed $3 million. A major cost of SCI is impaired mobility. Limited mobility contributes to decreased ability to work, increased care requirements, secondary injury, depression, bone mineral density loss, diabetes, and decreased cardiovascular health. Among ambulatory individuals with iSCI, residual balance deficits are common and are strongly correlated with both functional walking ability and participation in walking activities. The development of effective rehabilitation tools to improve dynamic balance would substantially improve quality of life for Veterans living with iSCI. Improving mobility through interventions that enhance dynamic balance would positively impact health, independence, and the ability to integrate into social, intellectual, and occupational environments.
Interventions
- DEVICE Gait training performed on a treadmill
- DEVICE Gait training performed in a Movement Amplification Environment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2020-10-15 |
| Est. Completion | 2024-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04340063
The ClinicalTrials.gov registry entry for NCT04340063 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gait training performed on a treadmill is the first listed.
NCT04340063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04340063 about?
NCT04340063 is a clinical study titled "Amplify Gait to Improve Locomotor Engagement in Spinal Cord Injury". Spinal cord injury (SCI) affects \~42,000 Veterans. The VA provides the single largest network of SCI care in the nation. The lifetime financial burden of SCI can exceed $3 million. A major cost of SCI is impaired mobility. Limited mobility contributes to decreased ability to work, increased care re...
What is the current status of trial NCT04340063?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2020-10-15. Estimated completion is 2024-03-31.
What interventions are being tested in trial NCT04340063?
The interventions under investigation include: Gait training performed on a treadmill (DEVICE), Gait training performed in a Movement Amplification Environment (DEVICE).
Who is sponsoring clinical trial NCT04340063?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.